Works matching DE "IMMUNE checkpoint inhibitors"

Results: 5000

Evaluation of colitis induced by immune-checkpoint inhibitors therapy in melanoma patients by an overall grading scale.

Published in:

Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 4, p. 569, doi. 10.1177/10781552241248057

By:

Nguyen, Trang L.;
Tew, Alice;
Kirton, Laura;
Steven, Neil

Publication type:

Article

Diagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience.

Published in:

Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 4, p. 641, doi. 10.1177/10781552241252627

By:

Elghawy, Omar;
Patel, Reema;
Barsouk, Adam;
Puthumana, Joe;
Xu, Jason;
Sussman, Jonathan;
Horton, Bethany;
Kaur, Varinder

Publication type:

Article

Immune-related adverse effects: Recognition and initiation of appropriate treatment in cancer patients on immunotherapy.

Published in:

Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 4, p. 563, doi. 10.1177/10781552241247477

By:

Mohr, Riley;
Howard, Anna;
Townsend, Melanie

Publication type:

Article

Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma.

Published in:

Expert Review of Precision Medicine & Drug Development, 2024, v. 9, n. 1, p. 17, doi. 10.1080/23808993.2024.2330422

By:

Mollica, Veronica;
Rosellini, Matteo;
Brocchi, Stefano;
Galuppi, Francesco;
Paccapelo, Alexandro;
Tateo, Valentina;
Marchetti, Andrea;
Tassinari, Elisa;
Mantuano, Francesco;
Santoni, Matteo;
Massari, Francesco

Publication type:

Article

Investigating tumor immunogenicity as a determinant of differential abscopal effects Open Access.

Published in:

Journal of Radiation Research, 2025, v. 66, n. 3, p. 253, doi. 10.1093/jrr/rraf021

By:

Jeong, Yoon Seok;
Lee, Kyoung Jin;
Kim, Yeon Ju;
Lee, Seung Jin;
Koom, Woong Sub;
Lee, Ik Jae;
Kim, Kyung Hwan

Publication type:

Article

Onco-rheumatology: from rags to riches, a transdisciplinary evolution Open Access.

Published in:

Rheumatology Advances in Practice, 2025, v. 9, n. 2, p. 1, doi. 10.1093/rap/rkaf053

By:

Marotto, Daniela;
Martinelli, Canio;
Maiorano, Patrizia;
Fioravanti, Antonella;
Amato, Patrizia;
Baglio, Giovanni;
Calugi, Graziella;
Fiorillo, Andrea;
Franchina, Tindara;
Gimigliano, Francesca;
Iolascon, Giovanni;
Maggio, Maria Cristina;
Mutti, Luciano;
Pirtoli, Luigi;
Giordano, Antonio

Publication type:

Article

Evaluating Patient Adherence and Persistence to Tyrosine-Kinase Inhibitors for Metastatic Renal Cell Carcinoma: A Retrospective Analysis of Real-World Data.

Published in:

Clinical Medicine Insights: Oncology, 2025, p. 1, doi. 10.1177/11795549251341877

By:

Arter, Zhaohui Liao;
Benjamin, David J;
Cao, Yen;
Farias, Jorge;
Thirumaran, Ranjit Kumar;
Forsyth, Michael;
Mar, Nataliya;
Rezazadeh Kalebasty, Arash

Publication type:

Article

The Treatment of Pembrolizumab-Induced Pruritus with Topical Roflumilast Cream 0.3% Once Daily.

Published in:

Journal of Clinical & Aesthetic Dermatology, 2025, v. 18, n. 5, p. 36

By:

LOMAX, LAURA

Publication type:

Article

A Review of Neoadjuvant PD-1 Inhibitors in the Setting of Cutaneous Malignancies.

Published in:

Journal of Clinical & Aesthetic Dermatology, 2025, v. 18, n. 5, p. 30

By:

DARNALL, ARIEL R.;
BALTAZAR, DAVID;
HAMANN, DATHAN;
ZEITOUNI, NATHALIE;
MOSER, JUSTIN

Publication type:

Article

Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy.

Published in:

Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01717-y

By:

Hu, Qin;
Zhu, Yifei;
Mei, Jie;
Liu, Ying;
Zhou, Guoren

Publication type:

Article

Chemotherapy-induced immunogenic cell death in combination with ICIs: a brief review of mechanisms, clinical insights, and therapeutic implications.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1572195

By:

Li, Chengwei;
Qi, Xiaoyan;
Yan, Min

Publication type:

Article

Editorial: Overcoming therapeutic resistance in head and neck squamous cell carcinoma.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1611819

By:

Roy, Souvick;
Sen, Prakriti;
Kar, Madhabananda;
Banerjee, Birendranath

Publication type:

Article

Imaging-based assessment of response to olaparib in platinum-sensitive relapsed ovarian cancer patients.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1546324

By:

Delgado-Ortet, Maria;
Bura, Vlad;
Funingana, Ionut-Gabriel;
Hulse, David;
Rundo, Leonardo;
Brenton, James D.;
Sala, Evis;
Escudero Sanchez, Lorena

Publication type:

Article

T cell subsets in cervical cancer tumor microenvironment: advances and therapeutic opportunities.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1612032

By:

Guo, Weilin;
Dai, Lan;
Qiu, Lihua

Publication type:

Article

Inhibition of human gastric cancer growth by cytokine-induced killer cells plus chemotherapy with or without cadonilimab in a mouse xenograft tumor model.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1609320

By:

Yang, Wenwei;
Liu, Jingwei;
Hou, Tiantian;
Lu, Xu;
Yang, Lin

Publication type:

Article

Bibliometric and visualized analysis of global distribution and research frontiers in tumor immune escape.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1586120

By:

Zhang, Chaihong;
Chen, Lihong

Publication type:

Article

Pseudomembranous Colitis: Unveiling an Infrequent Culprit Beyond Clostridium difficile —A Case Report.

Published in:

Journal of Investigative Medicine High Impact Case Reports, 2025, p. 1, doi. 10.1177/23247096251347401

By:

Ginjupalli, Manasa;
Jayakumar, Jayalekshmi;
Bandaru, Praneeth;
Kumar, Vikash;
Forlemu, Arnold;
Isaac Coss, Giovannie;
Etienne, Denzil;
Reddy, Madhavi

Publication type:

Article

Risk factors for type I leptomeningeal metastasis derived from non-small cell lung cancer and the impact of treatment for brain metastases on its development.

Published in:

Neuro-Oncology Practice, 2025, v. 12, n. 3, p. 448, doi. 10.1093/nop/npae118

By:

Iuchi, Toshihiko;
Shingyoji, Masato;
Mizuno, Satoko;
Ashinuma, Hironori;
Hasegawa, Yuzo;
Setoguchi, Taiki;
Hosono, Junji;
Sakaida, Tsukasa

Publication type:

Article

Natural killer cell therapies for non-oncological diseases: A narrative review.

Published in:

Marmara Medical Journal, 2025, v. 38, n. 2, p. 98, doi. 10.5472/marumj.1707952

By:

KIRKIK, Duygu;
AYDIN, Furkan;
KALKANLI TAS, Sevgi

Publication type:

Article

Evaluating the cost-effectiveness of atezolizumab-bevacizumab in advanced hepatocellular carcinoma: Insights from Taiwan.

Published in:

Journal of Food & Drug Analysis, 2025, v. 33, n. 2, p. 163, doi. 10.38212/2224-6614.3542

By:

Tsung-Wei Chang;
Wei-Chiao Chang;
Wan-Hsuan Chou;
Wei-Pin Chang;
Chun-Nan Kuo

Publication type:

Article

Exploration of predictive factors based on oral and intestinal bacterial flora for treating patients with urothelial carcinoma.

Published in:

PLoS ONE, 2025, v. 20, n. 6, p. 1, doi. 10.1371/journal.pone.0324814

By:

Matsumoto, Yuichi;
Hitaka, Yukihiro;
Hirata, Hiroshi;
Yamamoto, Yoshiaki;
Kobayashi, Keita;
Isoyama, Naohito;
Matsubara, Toshio;
Watanabe, Kenji;
Mizukami, Yoichi;
Nakagawa, Shin;
Mishima, Katsuaki;
Harada, Koji;
Shiraishi, Koji

Publication type:

Article

Editorial: The tumor microenvironment and immunotherapy for head and neck tumors.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1606787

By:

Jiang, Yifan;
Yang, Wenyi;
Hu, Jingzhou;
Tao, Lei

Publication type:

Article

Colonizable probiotic Lactobacillus paracasei R3 enhances ICI therapy via modulating PBMCs differentiation.

Published in:

Frontiers in Microbiology, 2025, p. 1, doi. 10.3389/fmicb.2025.1547964

By:

Song, Wencan;
Liu, Jizhen;
Yang, Jingfang;
Chen, Tao;
Zhu, Jiayi;
Liu, Xia

Publication type:

Article

Nanomaterials and immune checkpoint inhibitors in cancer immunotherapy: the synergistic innovation prospects.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1582774

By:

Chen, Jing;
Cheng, Xue

Publication type:

Article

Janus kinase and signal transducer and activator of transcription inhibitors in type 1 diabetes and immune checkpoint–related diabetes: current status and future perspectives.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1571247

By:

Su, Bowei;
Luan, Zhi-Lin;
Liu, Haixia;
Tuomilehto, Jaakko;
Ji, Xiaochen

Publication type:

Article

Treatment strategies for rapid recurrence and progression after surgery for stage I pulmonary pleomorphic carcinoma: a case report and literature review.

Published in:

2025

By:

Zhang, Jing;
Xiong, Wenji;
Wang, Hong;
Sun, Lemeng;
Chen, Chen;
Sun, Xueru;
Man, Xiuyue;
Yang, Lei;
Li, Zhihong

Publication type:

Case Study

Tumor marker pseudoprogression and immune-related cholangitis during conversion therapy for massive hepatocellular carcinoma: a case report.

Published in:

2025

By:

Zhang, Xiaodong;
Zhang, Luyi;
Zhao, Shuangying;
Dai, Lingling;
Li, Huayu;
Wu, Xudong;
Yan, Huanjun;
Lin, Rongfeng;
Zhu, Kelei

Publication type:

Case Study

TACE Empowers Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors in Unresectable HCC: A Multicenter Retrospective Study.

Published in:

Journal of Cancer, 2025, v. 16, n. 8, p. 2750, doi. 10.7150/jca.112706

By:

Yu Lei;
Yaowei Bai;
Xiatong Bai;
Jiacheng Liu;
Bo Sun;
Wenlong Wu;
Xiaoling Zhi;
Yang Su;
Hongsen Zhang;
Chuansheng Zheng

Publication type:

Article

Immune checkpoint inhibitor-induced thyroiditis and its potential mechanisms.

Published in:

Frontiers in Endocrinology, 2025, p. 1, doi. 10.3389/fendo.2025.1584675

By:

Mao, Xueqian;
Mao, Chaoming;
Liu, Jiameng;
Wang, Xi;
Mao, Yufei

Publication type:

Article

HAPIR: a refined Hallmark gene set-based machine learning approach for predicting immunotherapy response in cancer patients.

Published in:

NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00992-9

By:

Yuan, Mengqin;
Liu, Haizhou;
Huang, Yu-e;
Hou, Fei;
Wang, Lihong;
Wang, Quan;
Jiang, Wei

Publication type:

Article

MS-stable/TMB-high pleomorphic liposarcoma successfully treated with pembrolizumab: a case report.

Published in:

2025

By:

Miwa, Satoshi;
Kobayashi, Hiroshi;
Hirai, Toshihide;
Okajima, Koichi;
Ishibashi, Yuki;
Tsuda, Yusuke;
Zhang, Liuzhe;
Ando, Toshihiko;
Shinozaki-Ushiku, Aya;
Tanaka, Sakae

Publication type:

Case Study

Letter: Comparison of the Efficacy of Adjuvant PD‐1 Inhibitor After Curative Resection for Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Related HCC Versus Other Aetiologies.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 11, p. 1838, doi. 10.1111/apt.70102

By:

Su, Jia‐Yong;
Chen, Kang;
Liu, Zhen;
Luo, Min;
Liu, Shao‐Ping;
Ou, Jun‐Jie;
Su, Ze;
Li, Wen‐Feng;
He, Wen‐Hai;
Peng, Ning;
Ma, Liang;
Xiang, Bang‐De;
Zhong, Jian‐Hong

Publication type:

Article

Immunotherapy for triple-negative breast cancer: current trends and future prospects.

Published in:

Journal of the Egyptian National Cancer Institute, 2025, v. 37, n. 1, p. 1, doi. 10.1186/s43046-025-00295-x

By:

Essalihi, Amina;
Bouchra, Oumaima;
Khadiri, Khadija;
Khadrouf, Zineb;
Karkouri, Mehdi

Publication type:

Article

Predictive value of EBV-positivity in patients with gastric cancer treated with first-line nivolumab plus chemotherapy.

Published in:

Gastric Cancer, 2025, v. 28, n. 4, p. 631, doi. 10.1007/s10120-025-01618-6

By:

Kim, Hyung-Don;
Kim, So-Yeon;
Lee, Hyungeun;
Lee, Yuna;
Hyung, Jaewon;
Moon, Meesun;
Shin, Jinho;
Park, Young Soo;
Ryu, Min-Hee

Publication type:

Article

Lymphatic dissemination of HPV-positive oropharyngeal squamous cell carcinoma: underlying mechanisms and treatment innovations.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1601572

By:

Li, Xinyu;
Qiu, Hui;
Wu, Qiuji

Publication type:

Article

The comparison of efficacy and safety between cadonilimab (PD-1/CTLA-4) and anti-PD-1 inhibitors in patients with recurrent or metastatic cervical cancer: a retrospective real-world study.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1582299

By:

Pan, Baoyue;
Huang, He;
Wan, Ting;
Huang, Qidan;
He, Shanyang;
Xu, Shijie;
Chen, Siyu;
Yin, Jiaxin;
Li, Jundong;
Zheng, Min

Publication type:

Article

免疫检查点抑制剂联合抗血管生成药物治疗晚期非小细胞肺癌的研究进展.

Published in:

Cancer Research on Prevention & Treatment, 2025, v. 52, n. 6, p. 527, doi. 10.3971/j.issn.1000-8578.2025.24.1280

By:

曾爱菊;
马代远

Publication type:

Article

Neurological and Cardiac Adverse Events in Cervical Cancer Treatment: A Case of Postoperative Sintilimab-Induced Encephalitis and Myocarditis.

Published in:

2025

By:

Haiyu Guo;
Huanlei Wu;
Jun Li;
Runchao Li

Publication type:

Case Study

Outcomes of concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for melanoma brain metastases.

Published in:

Journal of Neuro-Oncology, 2025, v. 173, n. 3, p. 619, doi. 10.1007/s11060-025-05026-9

By:

Fu, Allen Ye;
Bernstein, Kenneth;
Zhang, Jeff;
Silverman, Joshua;
Mehnert, Janice;
Sulman, Erik P.;
Oermann, Eric Karl;
Kondziolka, Douglas

Publication type:

Article

Immune-related myocarditis characterized by malignant arrhythmia caused by conduction system involvement: case report and literature review.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1589990

By:

Zhan, Luying;
Qin, Zhiquan;
Yang, Liu;
Chen, Yun

Publication type:

Article

Splenic volume as a predictor of survival in cancer patients treated with immune checkpoint inhibitors.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1598484

By:

Zhang, Yunhua;
Fu, Xin;
Zhang, Lilong;
Zhou, Qing;
Wang, Weixing

Publication type:

Article

Case Report: Regenerative hepatic pseudotumor induced by tislelizumab in a lung cancer patient.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1565065

By:

Wang, Wenrui;
Li, Wei;
Zhang, Tianqi;
Jin, Zhenjing;
Yang, Lanlan

Publication type:

Article

Baseline profile peripheral Tfh cells predict immune-related adverse events in immune checkpoint inhibitor therapy of gastrointestinal cancer.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1559275

By:

Wang, Yifan;
Zhang, Zhening;
Xie, Tong;
Liu, Yudong;
Zhang, Cheng;
Li, Hao;
Feng, Ruiling;
Huang, Bo;
Liu, Qinghong;
Wang, Naidi;
Xing, Xiaoyan;
Han, Yipeng;
Li, Xue;
Wang, Ruoyi;
He, Jing;
Peng, Zhi

Publication type:

Article

Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1553882

By:

Ma, Hongfang;
Zhang, Shasha;
Jiao, Pengqing;
Ding, Haixia;
Wang, Fujun;
Zhao, Yue;
Wu, Jianhua;
Guo, Zhanjun

Publication type:

Article

T lymphocyte heterogeneity in NSCLC: implications for biomarker development and therapeutic innovation.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1604310

By:

Liu, Yu;
Qin, Denghui;
Fu, Jiejun

Publication type:

Article

Roles and functions of tumor-infiltrating lymphocytes and tertiary lymphoid structures in gastric cancer progression.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1595070

By:

Yao, Zhiyuan;
Li, Gengchen;
Pan, Di;
Pei, Zichen;
Fang, Yan;
Liu, Haonan;
Han, Zhengxiang

Publication type:

Article

Bispecific antibody for lung cancer: mechanisms and clinical insights.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1572802

By:

Chen, Wei;
Zhou, Afang;
Zhou, Yunfeng

Publication type:

Article

Cosibelimab.

Published in:: American Journal of Health-System Pharmacy, 2025, v. 82, n. 12, p. 638, doi. 10.1093/ajhp/zxaf055
Publication type:: Article

Hepatic artery infusion chemotherapy plus an immune checkpoint inhibitor and lenvatinib for the treatment of biliary tract carcinoma.

Published in:

World Journal of Surgical Oncology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12957-025-03882-3

By:

Wang, Junying;
Zhu, Guangyu;
Guo, Jinhe;
Teng, Gaojun

Publication type:

Article

Unraveling the role of HDAC3 as an immunotherapy prognostic biomarker and therapeutic target in advanced non-small cell lung cancer.

Published in:

Respiratory Research, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12931-025-03275-w

By:

Dai, Liyuan;
Huang, Liling;
Li, Lin;
Tang, Le;
Shi, Yuankai;
Han, Xiaohong

Publication type:

Article